CNS Pharmaceuticals, Inc. Gains 239.23%
Mon, May 04, 2026 at 07:41 PM
CNS Pharmaceuticals, Inc. (CNSP:NASDAQ) rocketted at $7.84, a gain of 239.2%. On Mon, May 04, 2026, CNSP:NASDAQ hit a New 2-Week High of $7.84. The stock got featured on our News Catalysts scanner on Mon, May 04, 2026 at 09:07 AM in the 'PRIVATE PLACEMENT' category. From Mon, Apr 20, 2026, the stock recorded 40.00% Up Days and 54.55% Green Days
The stock spiked on Mon, May 04, 2026 at $10.54 with a volume of 83M+.
About CNS Pharmaceuticals, Inc. (CNSP:NASDAQ)
CNS Pharmaceuticals Inc is a preclinical stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma.
Top 10 Gainers:
- SKK Holdings Limited (SKK:NASDAQ), 596.53%
- CNS Pharmaceuticals, Inc. (CNSP:NASDAQ), 239.23%
- Skycorp Solar Group Ltd (PN:NASDAQ), 89.18%
- Julong Holding Limited (JLHL:NASDAQ), 72.84%
- Elong Power Holding Limited (ELPW:NASDAQ), 65.84%
- Global Business Travel Group, Inc. (GBTG:NYSE), 57.5%
- Cre8 Enterprise Limited (CRE:NASDAQ), 52.28%
- Huachen AI Parking Management Technology Holding Co., Ltd (HCAI:NASDAQ), 51.41%
- Rallybio Corporation (RLYB:NASDAQ), 50.05%
- Above Food Ingredients Inc. (ABVE:NASDAQ), 33.29%